tirzepatide surpass 4 Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial Lilly's tirzepatide achieves all primary
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14

02188-7/asset/1f15c5ee-e9c1-4058-8e74-d7dafaec62ef/main.assets/gr2.jpg)




.webp)






















